Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
160 hedge funds and large institutions have $1.5B invested in Epizyme, Inc in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 36 reducing their positions, and 21 closing their positions.
1,585% more call options, than puts
Call options by funds: $59.2M | Put options by funds: $3.52M
86% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 36
86% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 21
12% more funds holding
Funds holding: 143 → 160 (+17)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
2% more capital invested
Capital invested by funds: $1.47B → $1.5B (+$29.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$26M |
| 2 |
State Street
Boston,
Massachusetts
|
+$23.2M |
| 3 |
BlackRock
New York
|
+$13.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.3M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$67.9M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$51.3M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$36M |
| 4 |
AG
Artal Group
Luxembourg
|
-$7.42M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.94M |
EPZM Hedge Fund Activity: Q2 2020 in Review
160 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2020, worth a combined $1.5B — up 2% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new EPZM positions and 21 closed out — a net gain of 18 holders — while 67 added to existing stakes and 36 trimmed.
The largest buyer was Primecap Management, adding an estimated $26M. The largest seller was NEA Management Company, exiting entirely with an estimated $67.9M sold.
- 160 institutional investors held Epizyme, Inc (EPZM) as of Q2 2020, up from 143 in Q1 2020.
- Funds reported $1.5B of Epizyme, Inc stock for Q2 2020, up 2% quarter-over-quarter.
- 39 funds opened new Epizyme, Inc positions in Q2 2020 and 21 closed out, a net change of +18 holders.
- The largest Epizyme, Inc buyer in Q2 2020 was Primecap Management, an estimated $26M added.
- The largest Epizyme, Inc seller in Q2 2020 was NEA Management Company, an estimated $67.9M sold.
Based on aggregated 13F filings for Q2 2020.